WAM
VBIV

Worth Asset Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Worth Asset Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-50
Closed -$165 – 456
2023
Q2 		$165 Hold
50
– – ﹤0.01% 443
2023
Q1 		$455 Hold
50
– – ﹤0.01% 456
2022
Q4 		$587 Hold
50
– – ﹤0.01% 441
2022
Q3 		$1K Hold
50
– – ﹤0.01% 443
2022
Q2 		$1K Hold
50
– – ﹤0.01% 518
2022
Q1 		$2K Buy
+50
New +$2.47K ﹤0.01% 491

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return